This excerpt taken from the ABII 8-K filed Nov 8, 2007.
We are a Delaware corporation that was formed in June 2007. Our chief executive officer and entities affiliated with him beneficially owned as of June 30, 2007 approximately 84% of Abraxis BioSciences common stock, excluding shares held in treasury, and will beneficially own the same percentage of our common stock immediately following the separation and related transactions. Our principal executive offices are located at 11755 Wilshire Boulevard, Suite 2000, Los Angeles, California 90025, and our telephone number is (310) 883-1300. Our internet address following the separation and related transactions will be www.abraxisbio.com. Information contained on our website does not and will not constitute a part of this information statement.
This information statement contains product names, trademarks and trade names of our company, including Abraxane®, nab and Coroxane, and other organizations.